Mary Teresa Shoemaker serves as Executive at Onconova Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mary Teresa Shoemaker has executed 3 insider transactions totaling $23.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 12, 2025 involved receiving (via award) 6,157 shares valued at $0.
Mary Teresa Shoemaker currently holds 6,292 shares of Onconova Therapeutics, Inc. (ONTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Teresa Shoemaker has been a net buyer of ONTX stock. They have purchased $23.2K and sold $0 worth of shares.
Mary Teresa Shoemaker's most recent insider trade was on Dec 12, 2025, when they sold 6,157 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.00 |
| Discretionary |
| Nov 25, 2020 | ONTX | $10.2K | Purchase | 37,735 | $0.27 | Discretionary |